ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY) Stock Price, Quote, News & History

Key Statistics

Open

$15.05

Volume / Avg.

56.59K / 186.56K

Day Range

$15.05 - $15.17

52 Wk Range

10.03 - 17.35

Market Cap

P/E Ratio

14.74

Dividend Yield

3.29%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Astellas Pharma Inc. News

Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer

FDA approves Pfizer and Astellas' PADCEV plus Keytruda for muscle-invasive bladder cancer, backed by Phase 3 survival data.

Vandana Singh

Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle

Sangamo files for Chapter 11 as Eli Lilly and Astellas step in to buy its valuable gene therapy and genome-editing assets.

Vandana Singh

These Analysts Boost Their Forecasts On Vir Biotechnology

Avi Kapoor

What's Going On With Kyntra Bio Stock Tuesday?

Kyntra Bio announces positive data for FG-3246 plus enzalutamide in metastatic castration-resistant prostate cancer.

Vandana Singh

Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why

Vir Biotechnology stock skyrockets after $335 million Astellas deal, strong prostate cancer data, and upbeat earnings boost outlook.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

560.19B

Investing Cash Flow (TTM)

-66.72B

Financing Cash Flow (TTM)

-404.78B

Free Cash Flow (TTM)

475.54B

Capital Expenditure (TTM)

-84.65B

Net Change in Cash (TTM)

88.69B

Valuation Metrics

Enterprise Value

$29.25B

PE Ratio (TTM)

14.74

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.01

PB Ratio (TTM)

2.21

Earnings Yield % (TTM)

6.78%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

7.94

Price / EBITDA (TTM)

7.34

Price / Free Cash Flow (TTM)

9.04

Book Value / Share

$6.81

Company Debt

Total Debt

$565.95B

LT Debt

$320.00B

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$81.79B

Total Cash

$281.61B

Debt to Equity

0.30

Issuance of Debt (TTM)

-$81.79B

Repayment of Debt (TTM)

-$81.79B

Key Statistics

Open

$15.05

Volume / Avg.

56.59K / 186.56K

Day Range

$15.05 - $15.17

52 Wk Range

10.03 - 17.35

Market Cap

P/E Ratio

14.74

Dividend Yield

3.29%

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Astellas Pharma Inc is a specialty international pharmaceutical company. The company focuses on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-tr...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

ALPMY

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

ALPMY

FAQ

How do I buy ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY) stock?

You can purchase shares of ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (OTCPK:ALPMY) through any online brokerage.

View our list of the best stock brokerages

Who are ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY) competitors?

There are no as such competitors for ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc..

What is the forecast, or price target, for ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY) stock?

There is no analysis for ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. to provide a consensus price target.

What is the current price for ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)?

The stock price for ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (OTCPK: ALPMY) is $15.1456 last updated August 25, 2026 at 12:20 PM EDT.

Does ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY) pay a dividend?

There are no upcoming dividends for ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc..

When is ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (OTCPK:ALPMY) reporting earnings?

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. does not have any upcoming earnings scheduled.

Is ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY) going to split?

There is no upcoming split for ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc..

What sector and industry does ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY) operate in?

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.